Antigen processing ... of predicted tumor antigens originate from unmutated genomic sequences in melanoma and non-small cell lung cancer. The mechanism of HBsAg antigen presentation to T cells ...

Association of PD-L1 mRNA levels in plasma-derived exosomes with response to nivolumab and pembrolizumab in melanoma and NSCLC. This is an ASCO Meeting Abstract from the 2018 ASCO-SITC Clinical Immuno ...

The latest data from studies across Bayer’s oncology and women’s health portfolios will be presented at the upcoming 2025 ...

A first-in-human phase 1, multicenter, open-label study of CB-011, a next-generation CRISPR-genome edited allogeneic anti-BCMA immune-cloaked CAR-T cell therapy, in patients with relapsed/refractory ...